ALB and Sepsis: Furthermore, early combination therapy (albumin given after crystalloid within the first 24 hours) has been associated with improved survival rates in sepsis patients, whereas non-early combination beyond 24 hours showed no such benefit, with survival advantages potentially confined to the first 28 days [18].